A Study to Evaluate the Efficacy and Safety of Intravitreal KSI-301 in Non-proliferative Diabetic Retinopathy (NPDR)
Clinical trial NCT05066230 · TERMINATED
Trial details
- NCT number
- NCT05066230
- Sponsor
- Kodiak Sciences Inc
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-07
- Primary completion
- 2023-08-03
- Enrollment
- 253
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.